NCT02219347View on ClinicalTrials.gov

Biomarkers of Remission in Rheumatoid Arthritis (BioRRA)

NACompletedINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

August 31, 2017

Study Completion Date

August 31, 2017

Conditions
Rheumatoid Arthritis
Interventions
DRUG

DMARD cessation

Complete cessation of non-biologic DMARD therapy (single or combination of methotrexate, sulphasalazine and/or hydroxychloroquine)

Trial Locations (1)

NE1 4LP

Newcastle NIHR Clinical Research Facility, Royal Victoria Infirmary, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne

All Listed Sponsors
collaborator

Newcastle University

OTHER

collaborator

Wellcome Trust

OTHER

lead

Newcastle-upon-Tyne Hospitals NHS Trust

OTHER

NCT02219347 - Biomarkers of Remission in Rheumatoid Arthritis (BioRRA) | Biotech Hunter | Biotech Hunter